What is the dose of Hemocoagulase (0.2 CU) in Botroclot (Hemocoagulase) drop for epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemocoagulase (Botroclot) Dosing for Epistaxis

The evidence provided does not contain any information about Hemocoagulase (Botroclot) dosing for epistaxis, and this agent is not mentioned in any major international guidelines for epistaxis management.

Evidence-Based Alternatives for Epistaxis Management

Since Hemocoagulase dosing information is not available in the evidence, I will outline the guideline-recommended approach to epistaxis management:

First-Line Treatment

  • Sit with head slightly forward and pinch the soft lower part of the nose for 10-15 minutes continuously without checking if bleeding has stopped 1, 2, 3
  • This nasal compression alone is sufficient in the vast majority of cases, including 20% of emergency department presentations 1, 2
  • The forward-leaning position prevents blood from entering the airway or stomach 1

If Bleeding Persists After Initial Compression

  • Apply topical tranexamic acid 1000 mg as it is 3.5 times more likely to achieve bleeding cessation compared to placebo (OR 3.5,95% CI 1.3-9.7) 4
  • The 1000 mg dose is superior to 500 mg, with 2.9 times less bleeding at 5 minutes and 4.3 times less rebleeding 5
  • Topical tranexamic acid reduces rebleeding risk from 66% to 43% within 10 days 6

Alternative Topical Agents

  • Topical vasoconstrictors (oxymetazoline or phenylephrine) can be applied after clearing clots, spraying twice in the bleeding nostril, then continuing compression for 5 minutes 3
  • Topical tranexamic acid is 2.35 times more effective than other topical hemostatic agents in stopping bleeding within 10 minutes (RR 2.35,95% CI 1.90-2.92) 6

When to Seek Medical Attention

  • Bleeding not controlled after 15 minutes of continuous manual pressure 1, 2, 3
  • Lightheadedness or signs of hemodynamic instability 1, 3
  • Epistaxis due to trauma with signs of brain injury, nasal deformity, or facial fracture 1

Common Pitfalls to Avoid

  • Insufficient compression time: Must maintain pressure for full 10-15 minutes without checking 2, 3
  • Using cryotherapy (ice): No evidence supports its use and it is not recommended 1, 2
  • Tilting head backward: This causes blood to enter the airway or stomach 1

Prevention of Recurrence

  • Apply petroleum jelly or other lubricating agents to the nasal mucosa after bleeding stops 3
  • Use saline nasal sprays to maintain moisture 3
  • Consider humidifier use in dry environments 3

Note: Without specific evidence for Hemocoagulase (Botroclot) dosing in epistaxis, I cannot provide a recommendation for this agent. The above represents the current evidence-based standard of care for epistaxis management according to major international guidelines 1, 2, 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Manejo de Epistaxis Relacionada con Apixaban

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Epistaxis in Patients on Ozempic (Semaglutide)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tranexamic acid for patients with nasal haemorrhage (epistaxis).

The Cochrane database of systematic reviews, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.